These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 518022)
1. [Determination of 6 pituitary hormones in the cerebrospinal fluid. Control subjects, prolactin adenomas, empty sella syndrome and hypothalamic disorders (author's transl)]. Turpin G; Heshmati HM; Roger M; Cesselin E; Lagoguey M; Baulieu JL; de Gennes JL Ann Endocrinol (Paris); 1979; 40(4):425-6. PubMed ID: 518022 [TBL] [Abstract][Full Text] [Related]
2. [Determination of pituitary hormones in cerebrospinal fluid in normal subjects and in hypothalamo-pituitary diseases. Secreting or non-secreting pituitary adenoma, empty sella syndrome, hypothalamic syndromes]. Turpin G; Heshmati HM; Roger M; Cesselin F; Lagoguey M; Baulieu JL; De Gennes JL Ann Endocrinol (Paris); 1980; 41(1):21-30. PubMed ID: 7396391 [TBL] [Abstract][Full Text] [Related]
3. Adenohypophyseal hormone levels in the cerebrospinal fluid of patients with pituitary disease. Dogliotti L; Faggiuolo R; Orlandi F; Paccotti P; Angeli A J Endocrinol Invest; 1983 Dec; 6(6):435-40. PubMed ID: 6423721 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid prolactin: a reflection of abnormal prolactin secretion in patients with pituitary tumors. Schroeder LL; Johnson JC; Malarkey WB J Clin Endocrinol Metab; 1976 Dec; 43(6):1255-60. PubMed ID: 1002815 [TBL] [Abstract][Full Text] [Related]
5. LH and FSH in human cerebrospinal fluid. Coculescu M; Oprescu M; Simionescu N; Pop A; Temeli E; IƤger AC; Constantinovici A Physiologie; 1985; 22(1):21-37. PubMed ID: 3919406 [TBL] [Abstract][Full Text] [Related]
6. Pituitary hormone concentrations in cerebrospinal fluid in patients with prolactin and growth hormone-secreting tumors. Rolandi E; Perria C; Cicchetti V; Sannia A; Magnani G; Rivano C; Michelozzi G; Barreca T J Neurosurg Sci; 1982; 26(3):173-8. PubMed ID: 7182436 [TBL] [Abstract][Full Text] [Related]
7. [Endocrinological evaluation of sellar and suprasellar tumor cases (the ninth report)--on the PRL levels in the CSF (author's transl)]. Matsumura S; Mori S; Yoshimoto H; Ohta M; Uozumi T No Shinkei Geka; 1977 Sep; 5(10):1057-63. PubMed ID: 909617 [TBL] [Abstract][Full Text] [Related]
8. [Growth hormone, prolactin, LH and FSH secretion in tissue culture of pituitary adenomas (author's transl)]. Kubo O; Himuro H; Kamijo Y; Kitamura K; Demura R No Shinkei Geka; 1977 Oct; 5(11):1135-41. PubMed ID: 917213 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of dynamic pituitary function testing in patients with hyperprolactinemia on diagnosis of pituitary prolactin-secreting adenoma (author's transl)]. Matsuura K Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):569-78. PubMed ID: 6806416 [TBL] [Abstract][Full Text] [Related]
10. Anterior pituitary hormone levels in the cerebrospinal fluid of patients with pituitary and parasellar tumors. Braunstein GD; Hassen G; Kamdar V; Nelson JC Fertil Steril; 1981 Aug; 36(2):164-72. PubMed ID: 6266883 [TBL] [Abstract][Full Text] [Related]
11. Altered specificity of the blood-cerebrospinal fluid barrier for pituitary hormones in patients with tumoral hypothalamo-hypophyseal diseases as proved by releasing hormones stimulation. Coculescu M; Poiana C; Pop A; Oprescu M; Constantinovici A; Simionescu N Physiologie; 1985; 22(4):269-92. PubMed ID: 3936071 [TBL] [Abstract][Full Text] [Related]
12. [Endocrinological evaluation of sellar and suprasellar tumor cases (the 2nd report);--on postoperative pituitary function (author's transl)]. Uozumi T; Mori S; Watanabe M; Takimoto N; Mogami H No Shinkei Geka; 1976 Jan; 4(1):73-8. PubMed ID: 176607 [TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone (LH) and prolactin-releasing pituitary tumor: possible malignant transformation of the LH cell line. Spertini F; Deruaz JP; Perentes E; Pelet B; Gomez F J Clin Endocrinol Metab; 1986 May; 62(5):849-54. PubMed ID: 3514650 [TBL] [Abstract][Full Text] [Related]
14. [Endocrinological evaluation of seller and suprasellar tumor cases (the third report)-on secreting chromophobe adenoma (author's transl)]. Uozumi T; Mori S; Watanabe M; Takimoto N; Mogami H No Shinkei Geka; 1976 Feb; 4(2):143-8. PubMed ID: 943720 [TBL] [Abstract][Full Text] [Related]
15. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture. Snyder PJ; Bashey HM; Phillips JL; Gennarelli TA J Clin Endocrinol Metab; 1985 Dec; 61(6):1061-5. PubMed ID: 2414310 [TBL] [Abstract][Full Text] [Related]
16. [Endocrinological evaluation of sellar and suprasellar tumor cases (the sixth report)-on pituitary hormone secretion of acromegalic patients before treatment (author's transl)]. Watanabe M; Takimoto N; Mogami H; Hashimoto T; Ohnishi T No Shinkei Geka; 1976 May; 4(5):465-70. PubMed ID: 945479 [TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors. Jordan RM; Kendall JW; Seaich JL; Allen JP; Paulsen CA; Kerber CW; Vanderlaan WP Ann Intern Med; 1976 Jul; 85(1):49-55. PubMed ID: 180861 [TBL] [Abstract][Full Text] [Related]
18. [Endocrinological evaluation of sellar and suprasellar tumor cases (author's transl)]. Mori S; Uozumi T; Watanabe M; Takimoto N; Mogami H No Shinkei Geka; 1976 Mar; 4(3):235-42. PubMed ID: 179027 [TBL] [Abstract][Full Text] [Related]
20. Chronobiological study of pituitary adenomas and of the empty sella syndrome. Ferrari E; Bossolo PA; Baldi F; Daguati M; Fioravanti M; Facara S Chronobiologia; 1982; 9(2):241-8. PubMed ID: 7117046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]